Table 1.

Demographic and clinical characteristics of 319 de novo AML patients

Sex, no.  
 Male 167  
 Female 152  
Age, median (range), y 45.1 (15.2-76.8)  
Age group, no.  
 Younger than 35 y 89  
 35-50 y 112  
 Older than 50 y 118  
FAB, no.  
 M0 10  
 M1 68 
 M2 74  
 M3 33  
 M4 56  
 M5 67 
 M6 4  
 Unclassified 7  
Cytogenetic risk group, no.  
 Favorable 57  
 Intermediate/unknown* 212 
 Unfavorable 50  
WBC count, median (range), 109/L 23.4 (0.3-282)  
Blast count, median (range), % 69 (0-98)  
Platelet count, median (range), 109/L 49 (3-931) 
Sex, no.  
 Male 167  
 Female 152  
Age, median (range), y 45.1 (15.2-76.8)  
Age group, no.  
 Younger than 35 y 89  
 35-50 y 112  
 Older than 50 y 118  
FAB, no.  
 M0 10  
 M1 68 
 M2 74  
 M3 33  
 M4 56  
 M5 67 
 M6 4  
 Unclassified 7  
Cytogenetic risk group, no.  
 Favorable 57  
 Intermediate/unknown* 212 
 Unfavorable 50  
WBC count, median (range), 109/L 23.4 (0.3-282)  
Blast count, median (range), % 69 (0-98)  
Platelet count, median (range), 109/L 49 (3-931) 

FAB indicates French-American-British classification21; and WBC, white blood cell.

*

For 6 patients of this group, no cytogenetic information was available at diagnosis.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal